VAERS reports by lot

Pfizer COVID-19 lot EW0202: VAERS reports

382 VAERS reports list lot EW0202 as a Pfizer COVID-19 vaccine, received between 2021-05-22 and 2024-05-08. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
382
Reports
12%
Marked serious
5
With a death outcome
21
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)29022%
Neurological21817%
Cardiac / Cardiovascular19415%
Gastrointestinal13410%
Respiratory1038%
Musculoskeletal1008%
Dermatological (non-injection-site)695%
Injection-site / Local reaction665%
Allergic / Anaphylactic524%
Psychiatric / Neuropsychiatric232%
Autoimmune / Immune-mediated171%
Thrombotic / Hematological141%
Reproductive / Menstrual91%

Where reports came from

U.S. state of the reporter, where given (top 12).

Ohio75
Texas33
California30
New York28
Puerto Rico23
Florida15
Michigan12
Missouri11
New Hampshire11
Virginia9
Colorado9
Minnesota8

Reports by month received

2021-0514
2021-06100
2021-0754
2021-0837
2021-0923
2021-1015
2021-1113
2021-129
2022-017
2022-0213
2022-0314
2022-046
2022-058
2022-0657
2022-073
2022-083
2022-091
2022-102
2023-121
2024-031
2024-051

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.